Cyproconazole is a triazole fungicide. This compound at 100 and 200 ppm has been observed in CD-1 mice to cause hepatocellular adenomas and carcinomas with the short term effects being constitutive androstane receptor dependent and similar to those of phenobarbital. In addition to the Cyproconazole effects listed induction of constitutive androstane receptor genes Cyp2b10 and Gadd45β were observed. Cyproconazole is an inhibitor of CYP51A1.
1. Mol, H.G., et al. 2007. Anal Bioanal Chem. 389: 1715-1754. PMID: 17563885
2. Peffer, R.C., et al. 2007. Toxicol. Sci. 99: 315-325. PMID: 17557908
See how others have used Cyproconazole (CAS 94361-06-5). Click on the entry to view the PubMed entry .
PMID: # 30528767 Machado, SC.|Souza, BM.|de Aguiar Marciano, LP.|Souza Pereira, AF.|de Carvalho, DT.|Martins, I.| et al. 2019. J Chromatogr A. 1586: 9-17.
Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2021 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.